Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the <ul>C</ul>hildren with <ul>H</ul>IV <ul>E</ul>arly Anti<ul>r</ul>etroviral Therapy (CHER) Study

<p>Abstract</p> <p>Background</p> <p>Although otorrhea occurs commonly in HIV-infected infants, there are few data. We compared the incidence of otorrhea in infants receiving early vs deferred ART in the Children with HIV Early Antiretroviral (CHER) trial. Infants aged...

Full description

Bibliographic Details
Main Authors: Cornell Morna, van Rensburg Anita, Dobbels Els, Rabie Helena, Nachman Sharon, Sorour Gill, Taliep Reghana, Hainline Clotilde, Violari Avy, Madhi Shabir A, Cotton Mark F
Format: Article
Language:English
Published: BMC 2011-10-01
Series:BMC Research Notes
Online Access:http://www.biomedcentral.com/1756-0500/4/448